COVID-19 Impact on Global Diagnostic Nuclear Medicines Market Insights, Forecast to 2026
Diagnostic Nuclear Medicines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Diagnostic Nuclear Medicines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Diagnostic Nuclear Medicines market is segmented into
The Diagnostic Nuclear Medicines market is analysed and market size information is provided by regions (countries).
The key regions covered in the Diagnostic Nuclear Medicines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Diagnostic Nuclear Medicines Market Share Analysis
Diagnostic Nuclear Medicines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Diagnostic Nuclear Medicines business, the date to enter into the Diagnostic Nuclear Medicines market, Diagnostic Nuclear Medicines product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Diagnostic Nuclear Medicines market is segmented into
- Tc-99m
- F-18
- Other
- Oncology
- Cardiology
- Other
The Diagnostic Nuclear Medicines market is analysed and market size information is provided by regions (countries).
The key regions covered in the Diagnostic Nuclear Medicines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Diagnostic Nuclear Medicines Market Share Analysis
Diagnostic Nuclear Medicines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Diagnostic Nuclear Medicines business, the date to enter into the Diagnostic Nuclear Medicines market, Diagnostic Nuclear Medicines product introduction, recent developments, etc.
The major vendors covered:
- Bracco Imaging
- Bayer
- Curium Pharmaceuticals
- Nordion
- Triad Isotopes
- Lantheus
- GE Healthcare
- China Isotope & Radiation
- Jubilant Pharma
- Eli Lilly
- Novartis
- SIEMENS
- Dongcheng
- Navidea
1 STUDY COVERAGE
1.1 Diagnostic Nuclear Medicines Product Introduction
1.2 Market Segments
1.3 Key Diagnostic Nuclear Medicines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Diagnostic Nuclear Medicines Market Size Growth Rate by Type
1.4.2 Tc-99m
1.4.3 F-18
1.4.4 Other
1.5 Market by Application
1.5.1 Global Diagnostic Nuclear Medicines Market Size Growth Rate by Application
1.5.2 Oncology
1.5.3 Cardiology
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Diagnostic Nuclear Medicines Industry Impact
1.6.1 How the Covid-19 is Affecting the Diagnostic Nuclear Medicines Industry
1.6.1.1 Diagnostic Nuclear Medicines Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Diagnostic Nuclear Medicines Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Diagnostic Nuclear Medicines Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Diagnostic Nuclear Medicines Market Size Estimates and Forecasts
2.1.1 Global Diagnostic Nuclear Medicines Revenue 2015-2026
2.1.2 Global Diagnostic Nuclear Medicines Sales 2015-2026
2.2 Diagnostic Nuclear Medicines Market Size by Region: 2020 Versus 2026
2.2.1 Global Diagnostic Nuclear Medicines Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Diagnostic Nuclear Medicines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL DIAGNOSTIC NUCLEAR MEDICINES COMPETITOR LANDSCAPE BY PLAYERS
3.1 Diagnostic Nuclear Medicines Sales by Manufacturers
3.1.1 Diagnostic Nuclear Medicines Sales by Manufacturers (2015-2020)
3.1.2 Diagnostic Nuclear Medicines Sales Market Share by Manufacturers (2015-2020)
3.2 Diagnostic Nuclear Medicines Revenue by Manufacturers
3.2.1 Diagnostic Nuclear Medicines Revenue by Manufacturers (2015-2020)
3.2.2 Diagnostic Nuclear Medicines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Diagnostic Nuclear Medicines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Diagnostic Nuclear Medicines Revenue in 2019
3.2.5 Global Diagnostic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Diagnostic Nuclear Medicines Price by Manufacturers
3.4 Diagnostic Nuclear Medicines Manufacturing Base Distribution, Product Types
3.4.1 Diagnostic Nuclear Medicines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Diagnostic Nuclear Medicines Product Type
3.4.3 Date of International Manufacturers Enter into Diagnostic Nuclear Medicines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Diagnostic Nuclear Medicines Market Size by Type (2015-2020)
4.1.1 Global Diagnostic Nuclear Medicines Sales by Type (2015-2020)
4.1.2 Global Diagnostic Nuclear Medicines Revenue by Type (2015-2020)
4.1.3 Diagnostic Nuclear Medicines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Diagnostic Nuclear Medicines Market Size Forecast by Type (2021-2026)
4.2.1 Global Diagnostic Nuclear Medicines Sales Forecast by Type (2021-2026)
4.2.2 Global Diagnostic Nuclear Medicines Revenue Forecast by Type (2021-2026)
4.2.3 Diagnostic Nuclear Medicines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Diagnostic Nuclear Medicines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Diagnostic Nuclear Medicines Market Size by Application (2015-2020)
5.1.1 Global Diagnostic Nuclear Medicines Sales by Application (2015-2020)
5.1.2 Global Diagnostic Nuclear Medicines Revenue by Application (2015-2020)
5.1.3 Diagnostic Nuclear Medicines Price by Application (2015-2020)
5.2 Diagnostic Nuclear Medicines Market Size Forecast by Application (2021-2026)
5.2.1 Global Diagnostic Nuclear Medicines Sales Forecast by Application (2021-2026)
5.2.2 Global Diagnostic Nuclear Medicines Revenue Forecast by Application (2021-2026)
5.2.3 Global Diagnostic Nuclear Medicines Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Diagnostic Nuclear Medicines by Country
6.1.1 North America Diagnostic Nuclear Medicines Sales by Country
6.1.2 North America Diagnostic Nuclear Medicines Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Diagnostic Nuclear Medicines Market Facts & Figures by Type
6.3 North America Diagnostic Nuclear Medicines Market Facts & Figures by Application
7 EUROPE
7.1 Europe Diagnostic Nuclear Medicines by Country
7.1.1 Europe Diagnostic Nuclear Medicines Sales by Country
7.1.2 Europe Diagnostic Nuclear Medicines Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Diagnostic Nuclear Medicines Market Facts & Figures by Type
7.3 Europe Diagnostic Nuclear Medicines Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Diagnostic Nuclear Medicines by Region
8.1.1 Asia Pacific Diagnostic Nuclear Medicines Sales by Region
8.1.2 Asia Pacific Diagnostic Nuclear Medicines Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Diagnostic Nuclear Medicines Market Facts & Figures by Type
8.3 Asia Pacific Diagnostic Nuclear Medicines Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Diagnostic Nuclear Medicines by Country
9.1.1 Latin America Diagnostic Nuclear Medicines Sales by Country
9.1.2 Latin America Diagnostic Nuclear Medicines Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Diagnostic Nuclear Medicines Market Facts & Figures by Type
9.3 Central & South America Diagnostic Nuclear Medicines Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Diagnostic Nuclear Medicines by Country
10.1.1 Middle East and Africa Diagnostic Nuclear Medicines Sales by Country
10.1.2 Middle East and Africa Diagnostic Nuclear Medicines Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Diagnostic Nuclear Medicines Market Facts & Figures by Type
10.3 Middle East and Africa Diagnostic Nuclear Medicines Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Bracco Imaging
11.1.1 Bracco Imaging Corporation Information
11.1.2 Bracco Imaging Description, Business Overview and Total Revenue
11.1.3 Bracco Imaging Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bracco Imaging Diagnostic Nuclear Medicines Products Offered
11.1.5 Bracco Imaging Recent Development
11.2 Bayer
11.2.1 Bayer Corporation Information
11.2.2 Bayer Description, Business Overview and Total Revenue
11.2.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bayer Diagnostic Nuclear Medicines Products Offered
11.2.5 Bayer Recent Development
11.3 Curium Pharmaceuticals
11.3.1 Curium Pharmaceuticals Corporation Information
11.3.2 Curium Pharmaceuticals Description, Business Overview and Total Revenue
11.3.3 Curium Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Curium Pharmaceuticals Diagnostic Nuclear Medicines Products Offered
11.3.5 Curium Pharmaceuticals Recent Development
11.4 Nordion
11.4.1 Nordion Corporation Information
11.4.2 Nordion Description, Business Overview and Total Revenue
11.4.3 Nordion Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Nordion Diagnostic Nuclear Medicines Products Offered
11.4.5 Nordion Recent Development
11.5 Triad Isotopes
11.5.1 Triad Isotopes Corporation Information
11.5.2 Triad Isotopes Description, Business Overview and Total Revenue
11.5.3 Triad Isotopes Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Triad Isotopes Diagnostic Nuclear Medicines Products Offered
11.5.5 Triad Isotopes Recent Development
11.6 Lantheus
11.6.1 Lantheus Corporation Information
11.6.2 Lantheus Description, Business Overview and Total Revenue
11.6.3 Lantheus Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Lantheus Diagnostic Nuclear Medicines Products Offered
11.6.5 Lantheus Recent Development
11.7 GE Healthcare
11.7.1 GE Healthcare Corporation Information
11.7.2 GE Healthcare Description, Business Overview and Total Revenue
11.7.3 GE Healthcare Sales, Revenue and Gross Margin (2015-2020)
11.7.4 GE Healthcare Diagnostic Nuclear Medicines Products Offered
11.7.5 GE Healthcare Recent Development
11.8 China Isotope & Radiation
11.8.1 China Isotope & Radiation Corporation Information
11.8.2 China Isotope & Radiation Description, Business Overview and Total Revenue
11.8.3 China Isotope & Radiation Sales, Revenue and Gross Margin (2015-2020)
11.8.4 China Isotope & Radiation Diagnostic Nuclear Medicines Products Offered
11.8.5 China Isotope & Radiation Recent Development
11.9 Jubilant Pharma
11.9.1 Jubilant Pharma Corporation Information
11.9.2 Jubilant Pharma Description, Business Overview and Total Revenue
11.9.3 Jubilant Pharma Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Jubilant Pharma Diagnostic Nuclear Medicines Products Offered
11.9.5 Jubilant Pharma Recent Development
11.10 Eli Lilly
11.10.1 Eli Lilly Corporation Information
11.10.2 Eli Lilly Description, Business Overview and Total Revenue
11.10.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Eli Lilly Diagnostic Nuclear Medicines Products Offered
11.10.5 Eli Lilly Recent Development
11.1 Bracco Imaging
11.1.1 Bracco Imaging Corporation Information
11.1.2 Bracco Imaging Description, Business Overview and Total Revenue
11.1.3 Bracco Imaging Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bracco Imaging Diagnostic Nuclear Medicines Products Offered
11.1.5 Bracco Imaging Recent Development
11.12 SIEMENS
11.12.1 SIEMENS Corporation Information
11.12.2 SIEMENS Description, Business Overview and Total Revenue
11.12.3 SIEMENS Sales, Revenue and Gross Margin (2015-2020)
11.12.4 SIEMENS Products Offered
11.12.5 SIEMENS Recent Development
11.13 Dongcheng
11.13.1 Dongcheng Corporation Information
11.13.2 Dongcheng Description, Business Overview and Total Revenue
11.13.3 Dongcheng Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Dongcheng Products Offered
11.13.5 Dongcheng Recent Development
11.14 Navidea
11.14.1 Navidea Corporation Information
11.14.2 Navidea Description, Business Overview and Total Revenue
11.14.3 Navidea Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Navidea Products Offered
11.14.5 Navidea Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Diagnostic Nuclear Medicines Market Estimates and Projections by Region
12.1.1 Global Diagnostic Nuclear Medicines Sales Forecast by Regions 2021-2026
12.1.2 Global Diagnostic Nuclear Medicines Revenue Forecast by Regions 2021-2026
12.2 North America Diagnostic Nuclear Medicines Market Size Forecast (2021-2026)
12.2.1 North America: Diagnostic Nuclear Medicines Sales Forecast (2021-2026)
12.2.2 North America: Diagnostic Nuclear Medicines Revenue Forecast (2021-2026)
12.2.3 North America: Diagnostic Nuclear Medicines Market Size Forecast by Country (2021-2026)
12.3 Europe Diagnostic Nuclear Medicines Market Size Forecast (2021-2026)
12.3.1 Europe: Diagnostic Nuclear Medicines Sales Forecast (2021-2026)
12.3.2 Europe: Diagnostic Nuclear Medicines Revenue Forecast (2021-2026)
12.3.3 Europe: Diagnostic Nuclear Medicines Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Diagnostic Nuclear Medicines Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Diagnostic Nuclear Medicines Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Diagnostic Nuclear Medicines Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Diagnostic Nuclear Medicines Market Size Forecast by Region (2021-2026)
12.5 Latin America Diagnostic Nuclear Medicines Market Size Forecast (2021-2026)
12.5.1 Latin America: Diagnostic Nuclear Medicines Sales Forecast (2021-2026)
12.5.2 Latin America: Diagnostic Nuclear Medicines Revenue Forecast (2021-2026)
12.5.3 Latin America: Diagnostic Nuclear Medicines Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Diagnostic Nuclear Medicines Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Diagnostic Nuclear Medicines Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Diagnostic Nuclear Medicines Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Diagnostic Nuclear Medicines Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Diagnostic Nuclear Medicines Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Diagnostic Nuclear Medicines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Diagnostic Nuclear Medicines Product Introduction
1.2 Market Segments
1.3 Key Diagnostic Nuclear Medicines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Diagnostic Nuclear Medicines Market Size Growth Rate by Type
1.4.2 Tc-99m
1.4.3 F-18
1.4.4 Other
1.5 Market by Application
1.5.1 Global Diagnostic Nuclear Medicines Market Size Growth Rate by Application
1.5.2 Oncology
1.5.3 Cardiology
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Diagnostic Nuclear Medicines Industry Impact
1.6.1 How the Covid-19 is Affecting the Diagnostic Nuclear Medicines Industry
1.6.1.1 Diagnostic Nuclear Medicines Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Diagnostic Nuclear Medicines Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Diagnostic Nuclear Medicines Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Diagnostic Nuclear Medicines Market Size Estimates and Forecasts
2.1.1 Global Diagnostic Nuclear Medicines Revenue 2015-2026
2.1.2 Global Diagnostic Nuclear Medicines Sales 2015-2026
2.2 Diagnostic Nuclear Medicines Market Size by Region: 2020 Versus 2026
2.2.1 Global Diagnostic Nuclear Medicines Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Diagnostic Nuclear Medicines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL DIAGNOSTIC NUCLEAR MEDICINES COMPETITOR LANDSCAPE BY PLAYERS
3.1 Diagnostic Nuclear Medicines Sales by Manufacturers
3.1.1 Diagnostic Nuclear Medicines Sales by Manufacturers (2015-2020)
3.1.2 Diagnostic Nuclear Medicines Sales Market Share by Manufacturers (2015-2020)
3.2 Diagnostic Nuclear Medicines Revenue by Manufacturers
3.2.1 Diagnostic Nuclear Medicines Revenue by Manufacturers (2015-2020)
3.2.2 Diagnostic Nuclear Medicines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Diagnostic Nuclear Medicines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Diagnostic Nuclear Medicines Revenue in 2019
3.2.5 Global Diagnostic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Diagnostic Nuclear Medicines Price by Manufacturers
3.4 Diagnostic Nuclear Medicines Manufacturing Base Distribution, Product Types
3.4.1 Diagnostic Nuclear Medicines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Diagnostic Nuclear Medicines Product Type
3.4.3 Date of International Manufacturers Enter into Diagnostic Nuclear Medicines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Diagnostic Nuclear Medicines Market Size by Type (2015-2020)
4.1.1 Global Diagnostic Nuclear Medicines Sales by Type (2015-2020)
4.1.2 Global Diagnostic Nuclear Medicines Revenue by Type (2015-2020)
4.1.3 Diagnostic Nuclear Medicines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Diagnostic Nuclear Medicines Market Size Forecast by Type (2021-2026)
4.2.1 Global Diagnostic Nuclear Medicines Sales Forecast by Type (2021-2026)
4.2.2 Global Diagnostic Nuclear Medicines Revenue Forecast by Type (2021-2026)
4.2.3 Diagnostic Nuclear Medicines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Diagnostic Nuclear Medicines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Diagnostic Nuclear Medicines Market Size by Application (2015-2020)
5.1.1 Global Diagnostic Nuclear Medicines Sales by Application (2015-2020)
5.1.2 Global Diagnostic Nuclear Medicines Revenue by Application (2015-2020)
5.1.3 Diagnostic Nuclear Medicines Price by Application (2015-2020)
5.2 Diagnostic Nuclear Medicines Market Size Forecast by Application (2021-2026)
5.2.1 Global Diagnostic Nuclear Medicines Sales Forecast by Application (2021-2026)
5.2.2 Global Diagnostic Nuclear Medicines Revenue Forecast by Application (2021-2026)
5.2.3 Global Diagnostic Nuclear Medicines Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Diagnostic Nuclear Medicines by Country
6.1.1 North America Diagnostic Nuclear Medicines Sales by Country
6.1.2 North America Diagnostic Nuclear Medicines Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Diagnostic Nuclear Medicines Market Facts & Figures by Type
6.3 North America Diagnostic Nuclear Medicines Market Facts & Figures by Application
7 EUROPE
7.1 Europe Diagnostic Nuclear Medicines by Country
7.1.1 Europe Diagnostic Nuclear Medicines Sales by Country
7.1.2 Europe Diagnostic Nuclear Medicines Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Diagnostic Nuclear Medicines Market Facts & Figures by Type
7.3 Europe Diagnostic Nuclear Medicines Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Diagnostic Nuclear Medicines by Region
8.1.1 Asia Pacific Diagnostic Nuclear Medicines Sales by Region
8.1.2 Asia Pacific Diagnostic Nuclear Medicines Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Diagnostic Nuclear Medicines Market Facts & Figures by Type
8.3 Asia Pacific Diagnostic Nuclear Medicines Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Diagnostic Nuclear Medicines by Country
9.1.1 Latin America Diagnostic Nuclear Medicines Sales by Country
9.1.2 Latin America Diagnostic Nuclear Medicines Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Diagnostic Nuclear Medicines Market Facts & Figures by Type
9.3 Central & South America Diagnostic Nuclear Medicines Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Diagnostic Nuclear Medicines by Country
10.1.1 Middle East and Africa Diagnostic Nuclear Medicines Sales by Country
10.1.2 Middle East and Africa Diagnostic Nuclear Medicines Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Diagnostic Nuclear Medicines Market Facts & Figures by Type
10.3 Middle East and Africa Diagnostic Nuclear Medicines Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Bracco Imaging
11.1.1 Bracco Imaging Corporation Information
11.1.2 Bracco Imaging Description, Business Overview and Total Revenue
11.1.3 Bracco Imaging Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bracco Imaging Diagnostic Nuclear Medicines Products Offered
11.1.5 Bracco Imaging Recent Development
11.2 Bayer
11.2.1 Bayer Corporation Information
11.2.2 Bayer Description, Business Overview and Total Revenue
11.2.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bayer Diagnostic Nuclear Medicines Products Offered
11.2.5 Bayer Recent Development
11.3 Curium Pharmaceuticals
11.3.1 Curium Pharmaceuticals Corporation Information
11.3.2 Curium Pharmaceuticals Description, Business Overview and Total Revenue
11.3.3 Curium Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Curium Pharmaceuticals Diagnostic Nuclear Medicines Products Offered
11.3.5 Curium Pharmaceuticals Recent Development
11.4 Nordion
11.4.1 Nordion Corporation Information
11.4.2 Nordion Description, Business Overview and Total Revenue
11.4.3 Nordion Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Nordion Diagnostic Nuclear Medicines Products Offered
11.4.5 Nordion Recent Development
11.5 Triad Isotopes
11.5.1 Triad Isotopes Corporation Information
11.5.2 Triad Isotopes Description, Business Overview and Total Revenue
11.5.3 Triad Isotopes Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Triad Isotopes Diagnostic Nuclear Medicines Products Offered
11.5.5 Triad Isotopes Recent Development
11.6 Lantheus
11.6.1 Lantheus Corporation Information
11.6.2 Lantheus Description, Business Overview and Total Revenue
11.6.3 Lantheus Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Lantheus Diagnostic Nuclear Medicines Products Offered
11.6.5 Lantheus Recent Development
11.7 GE Healthcare
11.7.1 GE Healthcare Corporation Information
11.7.2 GE Healthcare Description, Business Overview and Total Revenue
11.7.3 GE Healthcare Sales, Revenue and Gross Margin (2015-2020)
11.7.4 GE Healthcare Diagnostic Nuclear Medicines Products Offered
11.7.5 GE Healthcare Recent Development
11.8 China Isotope & Radiation
11.8.1 China Isotope & Radiation Corporation Information
11.8.2 China Isotope & Radiation Description, Business Overview and Total Revenue
11.8.3 China Isotope & Radiation Sales, Revenue and Gross Margin (2015-2020)
11.8.4 China Isotope & Radiation Diagnostic Nuclear Medicines Products Offered
11.8.5 China Isotope & Radiation Recent Development
11.9 Jubilant Pharma
11.9.1 Jubilant Pharma Corporation Information
11.9.2 Jubilant Pharma Description, Business Overview and Total Revenue
11.9.3 Jubilant Pharma Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Jubilant Pharma Diagnostic Nuclear Medicines Products Offered
11.9.5 Jubilant Pharma Recent Development
11.10 Eli Lilly
11.10.1 Eli Lilly Corporation Information
11.10.2 Eli Lilly Description, Business Overview and Total Revenue
11.10.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Eli Lilly Diagnostic Nuclear Medicines Products Offered
11.10.5 Eli Lilly Recent Development
11.1 Bracco Imaging
11.1.1 Bracco Imaging Corporation Information
11.1.2 Bracco Imaging Description, Business Overview and Total Revenue
11.1.3 Bracco Imaging Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bracco Imaging Diagnostic Nuclear Medicines Products Offered
11.1.5 Bracco Imaging Recent Development
11.12 SIEMENS
11.12.1 SIEMENS Corporation Information
11.12.2 SIEMENS Description, Business Overview and Total Revenue
11.12.3 SIEMENS Sales, Revenue and Gross Margin (2015-2020)
11.12.4 SIEMENS Products Offered
11.12.5 SIEMENS Recent Development
11.13 Dongcheng
11.13.1 Dongcheng Corporation Information
11.13.2 Dongcheng Description, Business Overview and Total Revenue
11.13.3 Dongcheng Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Dongcheng Products Offered
11.13.5 Dongcheng Recent Development
11.14 Navidea
11.14.1 Navidea Corporation Information
11.14.2 Navidea Description, Business Overview and Total Revenue
11.14.3 Navidea Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Navidea Products Offered
11.14.5 Navidea Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Diagnostic Nuclear Medicines Market Estimates and Projections by Region
12.1.1 Global Diagnostic Nuclear Medicines Sales Forecast by Regions 2021-2026
12.1.2 Global Diagnostic Nuclear Medicines Revenue Forecast by Regions 2021-2026
12.2 North America Diagnostic Nuclear Medicines Market Size Forecast (2021-2026)
12.2.1 North America: Diagnostic Nuclear Medicines Sales Forecast (2021-2026)
12.2.2 North America: Diagnostic Nuclear Medicines Revenue Forecast (2021-2026)
12.2.3 North America: Diagnostic Nuclear Medicines Market Size Forecast by Country (2021-2026)
12.3 Europe Diagnostic Nuclear Medicines Market Size Forecast (2021-2026)
12.3.1 Europe: Diagnostic Nuclear Medicines Sales Forecast (2021-2026)
12.3.2 Europe: Diagnostic Nuclear Medicines Revenue Forecast (2021-2026)
12.3.3 Europe: Diagnostic Nuclear Medicines Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Diagnostic Nuclear Medicines Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Diagnostic Nuclear Medicines Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Diagnostic Nuclear Medicines Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Diagnostic Nuclear Medicines Market Size Forecast by Region (2021-2026)
12.5 Latin America Diagnostic Nuclear Medicines Market Size Forecast (2021-2026)
12.5.1 Latin America: Diagnostic Nuclear Medicines Sales Forecast (2021-2026)
12.5.2 Latin America: Diagnostic Nuclear Medicines Revenue Forecast (2021-2026)
12.5.3 Latin America: Diagnostic Nuclear Medicines Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Diagnostic Nuclear Medicines Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Diagnostic Nuclear Medicines Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Diagnostic Nuclear Medicines Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Diagnostic Nuclear Medicines Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Diagnostic Nuclear Medicines Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Diagnostic Nuclear Medicines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Diagnostic Nuclear Medicines Market Segments
Table 2. Ranking of Global Top Diagnostic Nuclear Medicines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Diagnostic Nuclear Medicines Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Tc-99m
Table 5. Major Manufacturers of F-18
Table 6. Major Manufacturers of Other
Table 7. COVID-19 Impact Global Market: (Four Diagnostic Nuclear Medicines Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Diagnostic Nuclear Medicines Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Diagnostic Nuclear Medicines Players to Combat Covid-19 Impact
Table 12. Global Diagnostic Nuclear Medicines Market Size Growth Rate by Application 2020-2026 (K Units)
Table 13. Global Diagnostic Nuclear Medicines Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 14. Global Diagnostic Nuclear Medicines Sales by Regions 2015-2020 (K Units)
Table 15. Global Diagnostic Nuclear Medicines Sales Market Share by Regions (2015-2020)
Table 16. Global Diagnostic Nuclear Medicines Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Diagnostic Nuclear Medicines Sales by Manufacturers (2015-2020) (K Units)
Table 18. Global Diagnostic Nuclear Medicines Sales Share by Manufacturers (2015-2020)
Table 19. Global Diagnostic Nuclear Medicines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Diagnostic Nuclear Medicines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diagnostic Nuclear Medicines as of 2019)
Table 21. Diagnostic Nuclear Medicines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Diagnostic Nuclear Medicines Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Diagnostic Nuclear Medicines Price (2015-2020) (USD/Unit)
Table 24. Diagnostic Nuclear Medicines Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Diagnostic Nuclear Medicines Product Type
Table 26. Date of International Manufacturers Enter into Diagnostic Nuclear Medicines Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Diagnostic Nuclear Medicines Sales by Type (2015-2020) (K Units)
Table 29. Global Diagnostic Nuclear Medicines Sales Share by Type (2015-2020)
Table 30. Global Diagnostic Nuclear Medicines Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Diagnostic Nuclear Medicines Revenue Share by Type (2015-2020)
Table 32. Diagnostic Nuclear Medicines Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 33. Global Diagnostic Nuclear Medicines Sales by Application (2015-2020) (K Units)
Table 34. Global Diagnostic Nuclear Medicines Sales Share by Application (2015-2020)
Table 35. North America Diagnostic Nuclear Medicines Sales by Country (2015-2020) (K Units)
Table 36. North America Diagnostic Nuclear Medicines Sales Market Share by Country (2015-2020)
Table 37. North America Diagnostic Nuclear Medicines Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Diagnostic Nuclear Medicines Revenue Market Share by Country (2015-2020)
Table 39. North America Diagnostic Nuclear Medicines Sales by Type (2015-2020) (K Units)
Table 40. North America Diagnostic Nuclear Medicines Sales Market Share by Type (2015-2020)
Table 41. North America Diagnostic Nuclear Medicines Sales by Application (2015-2020) (K Units)
Table 42. North America Diagnostic Nuclear Medicines Sales Market Share by Application (2015-2020)
Table 43. Europe Diagnostic Nuclear Medicines Sales by Country (2015-2020) (K Units)
Table 44. Europe Diagnostic Nuclear Medicines Sales Market Share by Country (2015-2020)
Table 45. Europe Diagnostic Nuclear Medicines Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Diagnostic Nuclear Medicines Revenue Market Share by Country (2015-2020)
Table 47. Europe Diagnostic Nuclear Medicines Sales by Type (2015-2020) (K Units)
Table 48. Europe Diagnostic Nuclear Medicines Sales Market Share by Type (2015-2020)
Table 49. Europe Diagnostic Nuclear Medicines Sales by Application (2015-2020) (K Units)
Table 50. Europe Diagnostic Nuclear Medicines Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Diagnostic Nuclear Medicines Sales by Region (2015-2020) (K Units)
Table 52. Asia Pacific Diagnostic Nuclear Medicines Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Diagnostic Nuclear Medicines Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Diagnostic Nuclear Medicines Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Diagnostic Nuclear Medicines Sales by Type (2015-2020) (K Units)
Table 56. Asia Pacific Diagnostic Nuclear Medicines Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Diagnostic Nuclear Medicines Sales by Application (2015-2020) (K Units)
Table 58. Asia Pacific Diagnostic Nuclear Medicines Sales Market Share by Application (2015-2020)
Table 59. Latin America Diagnostic Nuclear Medicines Sales by Country (2015-2020) (K Units)
Table 60. Latin America Diagnostic Nuclear Medicines Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Diagnostic Nuclear Medicines Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Diagnostic Nuclear Medicines Revenue Market Share by Country (2015-2020)
Table 63. Latin America Diagnostic Nuclear Medicines Sales by Type (2015-2020) (K Units)
Table 64. Latin America Diagnostic Nuclear Medicines Sales Market Share by Type (2015-2020)
Table 65. Latin America Diagnostic Nuclear Medicines Sales by Application (2015-2020) (K Units)
Table 66. Latin America Diagnostic Nuclear Medicines Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Diagnostic Nuclear Medicines Sales by Country (2015-2020) (K Units)
Table 68. Middle East and Africa Diagnostic Nuclear Medicines Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Diagnostic Nuclear Medicines Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Diagnostic Nuclear Medicines Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Diagnostic Nuclear Medicines Sales by Type (2015-2020) (K Units)
Table 72. Middle East and Africa Diagnostic Nuclear Medicines Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Diagnostic Nuclear Medicines Sales by Application (2015-2020) (K Units)
Table 74. Middle East and Africa Diagnostic Nuclear Medicines Sales Market Share by Application (2015-2020)
Table 75. Bracco Imaging Corporation Information
Table 76. Bracco Imaging Description and Major Businesses
Table 77. Bracco Imaging Diagnostic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Bracco Imaging Product
Table 79. Bracco Imaging Recent Development
Table 80. Bayer Corporation Information
Table 81. Bayer Description and Major Businesses
Table 82. Bayer Diagnostic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Bayer Product
Table 84. Bayer Recent Development
Table 85. Curium Pharmaceuticals Corporation Information
Table 86. Curium Pharmaceuticals Description and Major Businesses
Table 87. Curium Pharmaceuticals Diagnostic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Curium Pharmaceuticals Product
Table 89. Curium Pharmaceuticals Recent Development
Table 90. Nordion Corporation Information
Table 91. Nordion Description and Major Businesses
Table 92. Nordion Diagnostic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Nordion Product
Table 94. Nordion Recent Development
Table 95. Triad Isotopes Corporation Information
Table 96. Triad Isotopes Description and Major Businesses
Table 97. Triad Isotopes Diagnostic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Triad Isotopes Product
Table 99. Triad Isotopes Recent Development
Table 100. Lantheus Corporation Information
Table 101. Lantheus Description and Major Businesses
Table 102. Lantheus Diagnostic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Lantheus Product
Table 104. Lantheus Recent Development
Table 105. GE Healthcare Corporation Information
Table 106. GE Healthcare Description and Major Businesses
Table 107. GE Healthcare Diagnostic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. GE Healthcare Product
Table 109. GE Healthcare Recent Development
Table 110. China Isotope & Radiation Corporation Information
Table 111. China Isotope & Radiation Description and Major Businesses
Table 112. China Isotope & Radiation Diagnostic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. China Isotope & Radiation Product
Table 114. China Isotope & Radiation Recent Development
Table 115. Jubilant Pharma Corporation Information
Table 116. Jubilant Pharma Description and Major Businesses
Table 117. Jubilant Pharma Diagnostic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Jubilant Pharma Product
Table 119. Jubilant Pharma Recent Development
Table 120. Eli Lilly Corporation Information
Table 121. Eli Lilly Description and Major Businesses
Table 122. Eli Lilly Diagnostic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Eli Lilly Product
Table 124. Eli Lilly Recent Development
Table 125. Novartis Corporation Information
Table 126. Novartis Description and Major Businesses
Table 127. Novartis Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Novartis Product
Table 129. Novartis Recent Development
Table 130. SIEMENS Corporation Information
Table 131. SIEMENS Description and Major Businesses
Table 132. SIEMENS Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. SIEMENS Product
Table 134. SIEMENS Recent Development
Table 135. Dongcheng Corporation Information
Table 136. Dongcheng Description and Major Businesses
Table 137. Dongcheng Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Dongcheng Product
Table 139. Dongcheng Recent Development
Table 140. Navidea Corporation Information
Table 141. Navidea Description and Major Businesses
Table 142. Navidea Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. Navidea Product
Table 144. Navidea Recent Development
Table 145. Global Diagnostic Nuclear Medicines Sales Forecast by Regions (2021-2026) (K Units)
Table 146. Global Diagnostic Nuclear Medicines Sales Market Share Forecast by Regions (2021-2026)
Table 147. Global Diagnostic Nuclear Medicines Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 148. Global Diagnostic Nuclear Medicines Revenue Market Share Forecast by Regions (2021-2026)
Table 149. North America: Diagnostic Nuclear Medicines Sales Forecast by Country (2021-2026) (K Units)
Table 150. North America: Diagnostic Nuclear Medicines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 151. Europe: Diagnostic Nuclear Medicines Sales Forecast by Country (2021-2026) (K Units)
Table 152. Europe: Diagnostic Nuclear Medicines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 153. Asia Pacific: Diagnostic Nuclear Medicines Sales Forecast by Region (2021-2026) (K Units)
Table 154. Asia Pacific: Diagnostic Nuclear Medicines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 155. Latin America: Diagnostic Nuclear Medicines Sales Forecast by Country (2021-2026) (K Units)
Table 156. Latin America: Diagnostic Nuclear Medicines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 157. Middle East and Africa: Diagnostic Nuclear Medicines Sales Forecast by Country (2021-2026) (K Units)
Table 158. Middle East and Africa: Diagnostic Nuclear Medicines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 159. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 160. Key Challenges
Table 161. Market Risks
Table 162. Main Points Interviewed from Key Diagnostic Nuclear Medicines Players
Table 163. Diagnostic Nuclear Medicines Customers List
Table 164. Diagnostic Nuclear Medicines Distributors List
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
Table 1. Diagnostic Nuclear Medicines Market Segments
Table 2. Ranking of Global Top Diagnostic Nuclear Medicines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Diagnostic Nuclear Medicines Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Tc-99m
Table 5. Major Manufacturers of F-18
Table 6. Major Manufacturers of Other
Table 7. COVID-19 Impact Global Market: (Four Diagnostic Nuclear Medicines Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Diagnostic Nuclear Medicines Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Diagnostic Nuclear Medicines Players to Combat Covid-19 Impact
Table 12. Global Diagnostic Nuclear Medicines Market Size Growth Rate by Application 2020-2026 (K Units)
Table 13. Global Diagnostic Nuclear Medicines Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 14. Global Diagnostic Nuclear Medicines Sales by Regions 2015-2020 (K Units)
Table 15. Global Diagnostic Nuclear Medicines Sales Market Share by Regions (2015-2020)
Table 16. Global Diagnostic Nuclear Medicines Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Diagnostic Nuclear Medicines Sales by Manufacturers (2015-2020) (K Units)
Table 18. Global Diagnostic Nuclear Medicines Sales Share by Manufacturers (2015-2020)
Table 19. Global Diagnostic Nuclear Medicines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Diagnostic Nuclear Medicines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diagnostic Nuclear Medicines as of 2019)
Table 21. Diagnostic Nuclear Medicines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Diagnostic Nuclear Medicines Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Diagnostic Nuclear Medicines Price (2015-2020) (USD/Unit)
Table 24. Diagnostic Nuclear Medicines Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Diagnostic Nuclear Medicines Product Type
Table 26. Date of International Manufacturers Enter into Diagnostic Nuclear Medicines Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Diagnostic Nuclear Medicines Sales by Type (2015-2020) (K Units)
Table 29. Global Diagnostic Nuclear Medicines Sales Share by Type (2015-2020)
Table 30. Global Diagnostic Nuclear Medicines Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Diagnostic Nuclear Medicines Revenue Share by Type (2015-2020)
Table 32. Diagnostic Nuclear Medicines Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 33. Global Diagnostic Nuclear Medicines Sales by Application (2015-2020) (K Units)
Table 34. Global Diagnostic Nuclear Medicines Sales Share by Application (2015-2020)
Table 35. North America Diagnostic Nuclear Medicines Sales by Country (2015-2020) (K Units)
Table 36. North America Diagnostic Nuclear Medicines Sales Market Share by Country (2015-2020)
Table 37. North America Diagnostic Nuclear Medicines Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Diagnostic Nuclear Medicines Revenue Market Share by Country (2015-2020)
Table 39. North America Diagnostic Nuclear Medicines Sales by Type (2015-2020) (K Units)
Table 40. North America Diagnostic Nuclear Medicines Sales Market Share by Type (2015-2020)
Table 41. North America Diagnostic Nuclear Medicines Sales by Application (2015-2020) (K Units)
Table 42. North America Diagnostic Nuclear Medicines Sales Market Share by Application (2015-2020)
Table 43. Europe Diagnostic Nuclear Medicines Sales by Country (2015-2020) (K Units)
Table 44. Europe Diagnostic Nuclear Medicines Sales Market Share by Country (2015-2020)
Table 45. Europe Diagnostic Nuclear Medicines Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Diagnostic Nuclear Medicines Revenue Market Share by Country (2015-2020)
Table 47. Europe Diagnostic Nuclear Medicines Sales by Type (2015-2020) (K Units)
Table 48. Europe Diagnostic Nuclear Medicines Sales Market Share by Type (2015-2020)
Table 49. Europe Diagnostic Nuclear Medicines Sales by Application (2015-2020) (K Units)
Table 50. Europe Diagnostic Nuclear Medicines Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Diagnostic Nuclear Medicines Sales by Region (2015-2020) (K Units)
Table 52. Asia Pacific Diagnostic Nuclear Medicines Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Diagnostic Nuclear Medicines Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Diagnostic Nuclear Medicines Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Diagnostic Nuclear Medicines Sales by Type (2015-2020) (K Units)
Table 56. Asia Pacific Diagnostic Nuclear Medicines Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Diagnostic Nuclear Medicines Sales by Application (2015-2020) (K Units)
Table 58. Asia Pacific Diagnostic Nuclear Medicines Sales Market Share by Application (2015-2020)
Table 59. Latin America Diagnostic Nuclear Medicines Sales by Country (2015-2020) (K Units)
Table 60. Latin America Diagnostic Nuclear Medicines Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Diagnostic Nuclear Medicines Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Diagnostic Nuclear Medicines Revenue Market Share by Country (2015-2020)
Table 63. Latin America Diagnostic Nuclear Medicines Sales by Type (2015-2020) (K Units)
Table 64. Latin America Diagnostic Nuclear Medicines Sales Market Share by Type (2015-2020)
Table 65. Latin America Diagnostic Nuclear Medicines Sales by Application (2015-2020) (K Units)
Table 66. Latin America Diagnostic Nuclear Medicines Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Diagnostic Nuclear Medicines Sales by Country (2015-2020) (K Units)
Table 68. Middle East and Africa Diagnostic Nuclear Medicines Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Diagnostic Nuclear Medicines Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Diagnostic Nuclear Medicines Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Diagnostic Nuclear Medicines Sales by Type (2015-2020) (K Units)
Table 72. Middle East and Africa Diagnostic Nuclear Medicines Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Diagnostic Nuclear Medicines Sales by Application (2015-2020) (K Units)
Table 74. Middle East and Africa Diagnostic Nuclear Medicines Sales Market Share by Application (2015-2020)
Table 75. Bracco Imaging Corporation Information
Table 76. Bracco Imaging Description and Major Businesses
Table 77. Bracco Imaging Diagnostic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Bracco Imaging Product
Table 79. Bracco Imaging Recent Development
Table 80. Bayer Corporation Information
Table 81. Bayer Description and Major Businesses
Table 82. Bayer Diagnostic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Bayer Product
Table 84. Bayer Recent Development
Table 85. Curium Pharmaceuticals Corporation Information
Table 86. Curium Pharmaceuticals Description and Major Businesses
Table 87. Curium Pharmaceuticals Diagnostic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Curium Pharmaceuticals Product
Table 89. Curium Pharmaceuticals Recent Development
Table 90. Nordion Corporation Information
Table 91. Nordion Description and Major Businesses
Table 92. Nordion Diagnostic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Nordion Product
Table 94. Nordion Recent Development
Table 95. Triad Isotopes Corporation Information
Table 96. Triad Isotopes Description and Major Businesses
Table 97. Triad Isotopes Diagnostic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Triad Isotopes Product
Table 99. Triad Isotopes Recent Development
Table 100. Lantheus Corporation Information
Table 101. Lantheus Description and Major Businesses
Table 102. Lantheus Diagnostic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Lantheus Product
Table 104. Lantheus Recent Development
Table 105. GE Healthcare Corporation Information
Table 106. GE Healthcare Description and Major Businesses
Table 107. GE Healthcare Diagnostic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. GE Healthcare Product
Table 109. GE Healthcare Recent Development
Table 110. China Isotope & Radiation Corporation Information
Table 111. China Isotope & Radiation Description and Major Businesses
Table 112. China Isotope & Radiation Diagnostic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. China Isotope & Radiation Product
Table 114. China Isotope & Radiation Recent Development
Table 115. Jubilant Pharma Corporation Information
Table 116. Jubilant Pharma Description and Major Businesses
Table 117. Jubilant Pharma Diagnostic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Jubilant Pharma Product
Table 119. Jubilant Pharma Recent Development
Table 120. Eli Lilly Corporation Information
Table 121. Eli Lilly Description and Major Businesses
Table 122. Eli Lilly Diagnostic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Eli Lilly Product
Table 124. Eli Lilly Recent Development
Table 125. Novartis Corporation Information
Table 126. Novartis Description and Major Businesses
Table 127. Novartis Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Novartis Product
Table 129. Novartis Recent Development
Table 130. SIEMENS Corporation Information
Table 131. SIEMENS Description and Major Businesses
Table 132. SIEMENS Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. SIEMENS Product
Table 134. SIEMENS Recent Development
Table 135. Dongcheng Corporation Information
Table 136. Dongcheng Description and Major Businesses
Table 137. Dongcheng Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Dongcheng Product
Table 139. Dongcheng Recent Development
Table 140. Navidea Corporation Information
Table 141. Navidea Description and Major Businesses
Table 142. Navidea Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. Navidea Product
Table 144. Navidea Recent Development
Table 145. Global Diagnostic Nuclear Medicines Sales Forecast by Regions (2021-2026) (K Units)
Table 146. Global Diagnostic Nuclear Medicines Sales Market Share Forecast by Regions (2021-2026)
Table 147. Global Diagnostic Nuclear Medicines Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 148. Global Diagnostic Nuclear Medicines Revenue Market Share Forecast by Regions (2021-2026)
Table 149. North America: Diagnostic Nuclear Medicines Sales Forecast by Country (2021-2026) (K Units)
Table 150. North America: Diagnostic Nuclear Medicines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 151. Europe: Diagnostic Nuclear Medicines Sales Forecast by Country (2021-2026) (K Units)
Table 152. Europe: Diagnostic Nuclear Medicines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 153. Asia Pacific: Diagnostic Nuclear Medicines Sales Forecast by Region (2021-2026) (K Units)
Table 154. Asia Pacific: Diagnostic Nuclear Medicines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 155. Latin America: Diagnostic Nuclear Medicines Sales Forecast by Country (2021-2026) (K Units)
Table 156. Latin America: Diagnostic Nuclear Medicines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 157. Middle East and Africa: Diagnostic Nuclear Medicines Sales Forecast by Country (2021-2026) (K Units)
Table 158. Middle East and Africa: Diagnostic Nuclear Medicines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 159. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 160. Key Challenges
Table 161. Market Risks
Table 162. Main Points Interviewed from Key Diagnostic Nuclear Medicines Players
Table 163. Diagnostic Nuclear Medicines Customers List
Table 164. Diagnostic Nuclear Medicines Distributors List
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Diagnostic Nuclear Medicines Product Picture
Figure 2. Global Diagnostic Nuclear Medicines Sales Market Share by Type in 2020 & 2026
Figure 3. Tc-99m Product Picture
Figure 4. F-18 Product Picture
Figure 5. Other Product Picture
Figure 6. Global Diagnostic Nuclear Medicines Sales Market Share by Application in 2020 & 2026
Figure 7. Oncology
Figure 8. Cardiology
Figure 9. Other
Figure 10. Diagnostic Nuclear Medicines Report Years Considered
Figure 11. Global Diagnostic Nuclear Medicines Market Size 2015-2026 (US$ Million)
Figure 12. Global Diagnostic Nuclear Medicines Sales 2015-2026 (K Units)
Figure 13. Global Diagnostic Nuclear Medicines Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Diagnostic Nuclear Medicines Sales Market Share by Region (2015-2020)
Figure 15. Global Diagnostic Nuclear Medicines Sales Market Share by Region in 2019
Figure 16. Global Diagnostic Nuclear Medicines Revenue Market Share by Region (2015-2020)
Figure 17. Global Diagnostic Nuclear Medicines Revenue Market Share by Region in 2019
Figure 18. Global Diagnostic Nuclear Medicines Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Diagnostic Nuclear Medicines Revenue in 2019
Figure 20. Diagnostic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Diagnostic Nuclear Medicines Sales Market Share by Type (2015-2020)
Figure 22. Global Diagnostic Nuclear Medicines Sales Market Share by Type in 2019
Figure 23. Global Diagnostic Nuclear Medicines Revenue Market Share by Type (2015-2020)
Figure 24. Global Diagnostic Nuclear Medicines Revenue Market Share by Type in 2019
Figure 25. Global Diagnostic Nuclear Medicines Market Share by Price Range (2015-2020)
Figure 26. Global Diagnostic Nuclear Medicines Sales Market Share by Application (2015-2020)
Figure 27. Global Diagnostic Nuclear Medicines Sales Market Share by Application in 2019
Figure 28. Global Diagnostic Nuclear Medicines Revenue Market Share by Application (2015-2020)
Figure 29. Global Diagnostic Nuclear Medicines Revenue Market Share by Application in 2019
Figure 30. North America Diagnostic Nuclear Medicines Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America Diagnostic Nuclear Medicines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Diagnostic Nuclear Medicines Sales Market Share by Country in 2019
Figure 33. North America Diagnostic Nuclear Medicines Revenue Market Share by Country in 2019
Figure 34. U.S. Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Diagnostic Nuclear Medicines Market Share by Type in 2019
Figure 39. North America Diagnostic Nuclear Medicines Market Share by Application in 2019
Figure 40. Europe Diagnostic Nuclear Medicines Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe Diagnostic Nuclear Medicines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Diagnostic Nuclear Medicines Sales Market Share by Country in 2019
Figure 43. Europe Diagnostic Nuclear Medicines Revenue Market Share by Country in 2019
Figure 44. Germany Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 47. France Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Diagnostic Nuclear Medicines Market Share by Type in 2019
Figure 55. Europe Diagnostic Nuclear Medicines Market Share by Application in 2019
Figure 56. Asia Pacific Diagnostic Nuclear Medicines Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific Diagnostic Nuclear Medicines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Diagnostic Nuclear Medicines Sales Market Share by Region in 2019
Figure 59. Asia Pacific Diagnostic Nuclear Medicines Revenue Market Share by Region in 2019
Figure 60. China Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 61. China Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 67. India Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Diagnostic Nuclear Medicines Market Share by Type in 2019
Figure 83. Asia Pacific Diagnostic Nuclear Medicines Market Share by Application in 2019
Figure 84. Latin America Diagnostic Nuclear Medicines Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Diagnostic Nuclear Medicines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Diagnostic Nuclear Medicines Sales Market Share by Country in 2019
Figure 87. Latin America Diagnostic Nuclear Medicines Revenue Market Share by Country in 2019
Figure 88. Mexico Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Diagnostic Nuclear Medicines Market Share by Type in 2019
Figure 95. Latin America Diagnostic Nuclear Medicines Market Share by Application in 2019
Figure 96. Middle East and Africa Diagnostic Nuclear Medicines Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Diagnostic Nuclear Medicines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Diagnostic Nuclear Medicines Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Diagnostic Nuclear Medicines Revenue Market Share by Country in 2019
Figure 100. Turkey Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Diagnostic Nuclear Medicines Market Share by Type in 2019
Figure 107. Middle East and Africa Diagnostic Nuclear Medicines Market Share by Application in 2019
Figure 108. Bracco Imaging Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Curium Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Nordion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Triad Isotopes Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Lantheus Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. China Isotope & Radiation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Jubilant Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. SIEMENS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Dongcheng Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. Navidea Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. North America Diagnostic Nuclear Medicines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 123. North America Diagnostic Nuclear Medicines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Europe Diagnostic Nuclear Medicines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 125. Europe Diagnostic Nuclear Medicines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Asia Pacific Diagnostic Nuclear Medicines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 127. Asia Pacific Diagnostic Nuclear Medicines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Latin America Diagnostic Nuclear Medicines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 129. Latin America Diagnostic Nuclear Medicines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 130. Middle East and Africa Diagnostic Nuclear Medicines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 131. Middle East and Africa Diagnostic Nuclear Medicines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 132. Porter's Five Forces Analysis
Figure 133. Channels of Distribution
Figure 134. Distributors Profiles
Figure 135. Bottom-up and Top-down Approaches for This Report
Figure 136. Data Triangulation
Figure 137. Key Executives Interviewed
Figure 1. Diagnostic Nuclear Medicines Product Picture
Figure 2. Global Diagnostic Nuclear Medicines Sales Market Share by Type in 2020 & 2026
Figure 3. Tc-99m Product Picture
Figure 4. F-18 Product Picture
Figure 5. Other Product Picture
Figure 6. Global Diagnostic Nuclear Medicines Sales Market Share by Application in 2020 & 2026
Figure 7. Oncology
Figure 8. Cardiology
Figure 9. Other
Figure 10. Diagnostic Nuclear Medicines Report Years Considered
Figure 11. Global Diagnostic Nuclear Medicines Market Size 2015-2026 (US$ Million)
Figure 12. Global Diagnostic Nuclear Medicines Sales 2015-2026 (K Units)
Figure 13. Global Diagnostic Nuclear Medicines Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Diagnostic Nuclear Medicines Sales Market Share by Region (2015-2020)
Figure 15. Global Diagnostic Nuclear Medicines Sales Market Share by Region in 2019
Figure 16. Global Diagnostic Nuclear Medicines Revenue Market Share by Region (2015-2020)
Figure 17. Global Diagnostic Nuclear Medicines Revenue Market Share by Region in 2019
Figure 18. Global Diagnostic Nuclear Medicines Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Diagnostic Nuclear Medicines Revenue in 2019
Figure 20. Diagnostic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Diagnostic Nuclear Medicines Sales Market Share by Type (2015-2020)
Figure 22. Global Diagnostic Nuclear Medicines Sales Market Share by Type in 2019
Figure 23. Global Diagnostic Nuclear Medicines Revenue Market Share by Type (2015-2020)
Figure 24. Global Diagnostic Nuclear Medicines Revenue Market Share by Type in 2019
Figure 25. Global Diagnostic Nuclear Medicines Market Share by Price Range (2015-2020)
Figure 26. Global Diagnostic Nuclear Medicines Sales Market Share by Application (2015-2020)
Figure 27. Global Diagnostic Nuclear Medicines Sales Market Share by Application in 2019
Figure 28. Global Diagnostic Nuclear Medicines Revenue Market Share by Application (2015-2020)
Figure 29. Global Diagnostic Nuclear Medicines Revenue Market Share by Application in 2019
Figure 30. North America Diagnostic Nuclear Medicines Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America Diagnostic Nuclear Medicines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Diagnostic Nuclear Medicines Sales Market Share by Country in 2019
Figure 33. North America Diagnostic Nuclear Medicines Revenue Market Share by Country in 2019
Figure 34. U.S. Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Diagnostic Nuclear Medicines Market Share by Type in 2019
Figure 39. North America Diagnostic Nuclear Medicines Market Share by Application in 2019
Figure 40. Europe Diagnostic Nuclear Medicines Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe Diagnostic Nuclear Medicines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Diagnostic Nuclear Medicines Sales Market Share by Country in 2019
Figure 43. Europe Diagnostic Nuclear Medicines Revenue Market Share by Country in 2019
Figure 44. Germany Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 47. France Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Diagnostic Nuclear Medicines Market Share by Type in 2019
Figure 55. Europe Diagnostic Nuclear Medicines Market Share by Application in 2019
Figure 56. Asia Pacific Diagnostic Nuclear Medicines Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific Diagnostic Nuclear Medicines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Diagnostic Nuclear Medicines Sales Market Share by Region in 2019
Figure 59. Asia Pacific Diagnostic Nuclear Medicines Revenue Market Share by Region in 2019
Figure 60. China Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 61. China Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 67. India Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Diagnostic Nuclear Medicines Market Share by Type in 2019
Figure 83. Asia Pacific Diagnostic Nuclear Medicines Market Share by Application in 2019
Figure 84. Latin America Diagnostic Nuclear Medicines Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Diagnostic Nuclear Medicines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Diagnostic Nuclear Medicines Sales Market Share by Country in 2019
Figure 87. Latin America Diagnostic Nuclear Medicines Revenue Market Share by Country in 2019
Figure 88. Mexico Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Diagnostic Nuclear Medicines Market Share by Type in 2019
Figure 95. Latin America Diagnostic Nuclear Medicines Market Share by Application in 2019
Figure 96. Middle East and Africa Diagnostic Nuclear Medicines Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Diagnostic Nuclear Medicines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Diagnostic Nuclear Medicines Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Diagnostic Nuclear Medicines Revenue Market Share by Country in 2019
Figure 100. Turkey Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Diagnostic Nuclear Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E Diagnostic Nuclear Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Diagnostic Nuclear Medicines Market Share by Type in 2019
Figure 107. Middle East and Africa Diagnostic Nuclear Medicines Market Share by Application in 2019
Figure 108. Bracco Imaging Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Curium Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Nordion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Triad Isotopes Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Lantheus Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. China Isotope & Radiation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Jubilant Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. SIEMENS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Dongcheng Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. Navidea Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. North America Diagnostic Nuclear Medicines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 123. North America Diagnostic Nuclear Medicines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Europe Diagnostic Nuclear Medicines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 125. Europe Diagnostic Nuclear Medicines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Asia Pacific Diagnostic Nuclear Medicines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 127. Asia Pacific Diagnostic Nuclear Medicines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Latin America Diagnostic Nuclear Medicines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 129. Latin America Diagnostic Nuclear Medicines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 130. Middle East and Africa Diagnostic Nuclear Medicines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 131. Middle East and Africa Diagnostic Nuclear Medicines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 132. Porter's Five Forces Analysis
Figure 133. Channels of Distribution
Figure 134. Distributors Profiles
Figure 135. Bottom-up and Top-down Approaches for This Report
Figure 136. Data Triangulation
Figure 137. Key Executives Interviewed
